|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-10.30/-0.42
|
企業價值
107.27M
|
資產負債 |
每股賬面淨值
1.39
|
現金流量 |
現金流量率
--
|
損益表 |
收益
17.98M
|
每股收益
0.69
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/15 22:53 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. |